Form 4: Sangamo Therapeutics Director Courtney Beers Reports Stock and Option Transactions

Director Courtney Beers reported the acquisition of 25,000 shares of common stock and 50,000 stock options, along with the disposal of some shares.

Summary

• On June 4, 2024, Courtney Beers, a director of Sangamo Therapeutics, reported transactions involving the company's stock.
• Beers acquired 25,000 shares of common stock through a restricted stock unit (RSU) grant.
• These RSUs will fully vest on the earlier of June 4, 2025, or the day prior to the 2025 annual meeting of stockholders, contingent upon continuous service.
• Beers also acquired 50,000 stock options with an exercise price of $0.5676.
• The options are immediately exercisable, but unvested shares are subject to repurchase rights by the issuer.
• The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to continuous service.
• Beers also disposed of some shares, and following these transactions, Beers beneficially owns 57,650 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option transactions by a company director. The acquisitions could be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of stock and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedules of the RSUs and stock options are contingent upon the Reporting Person's continuous service, indicating an incentive for continued involvement with the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock option and RSU grants are common forms of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
• Vesting schedules tied to continuous service are standard practice to ensure long-term commitment.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment, as they indicate insider confidence.
• The vesting schedules incentivize the director to remain with the company, benefiting stakeholders through continued leadership.

Key Dates